SG Americas Securities LLC grew its position in DocGo Inc. (NASDAQ:DCGO – Free Report) by 97.5% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 38,147 shares of the company’s stock after acquiring an additional 18,835 shares during the period. SG Americas Securities LLC’s holdings in DocGo were worth $127,000 at the end of the most recent quarter.
Other large investors have also modified their holdings of the company. nVerses Capital LLC raised its position in shares of DocGo by 151.5% in the second quarter. nVerses Capital LLC now owns 8,300 shares of the company’s stock worth $26,000 after acquiring an additional 5,000 shares during the period. Gladius Capital Management LP acquired a new position in shares of DocGo in the second quarter worth about $34,000. Nisa Investment Advisors LLC raised its position in shares of DocGo by 693.2% in the second quarter. Nisa Investment Advisors LLC now owns 12,089 shares of the company’s stock worth $37,000 after acquiring an additional 10,565 shares during the period. Victory Capital Management Inc. raised its position in shares of DocGo by 124.0% in the second quarter. Victory Capital Management Inc. now owns 25,635 shares of the company’s stock worth $79,000 after acquiring an additional 14,191 shares during the period. Finally, The Manufacturers Life Insurance Company raised its position in shares of DocGo by 31.6% in the second quarter. The Manufacturers Life Insurance Company now owns 40,401 shares of the company’s stock worth $125,000 after acquiring an additional 9,696 shares during the period. Institutional investors and hedge funds own 56.44% of the company’s stock.
Analyst Upgrades and Downgrades
DCGO has been the subject of a number of analyst reports. Cantor Fitzgerald reiterated an “overweight” rating and issued a $5.00 price objective on shares of DocGo in a research report on Friday, September 20th. Needham & Company LLC restated a “buy” rating and set a $7.00 price target on shares of DocGo in a research report on Thursday, August 8th. Five research analysts have rated the stock with a buy rating, According to data from MarketBeat, DocGo has an average rating of “Buy” and an average target price of $6.10.
DocGo Stock Up 1.5 %
DCGO opened at $3.42 on Friday. DocGo Inc. has a twelve month low of $2.75 and a twelve month high of $6.90. The company has a 50-day moving average price of $3.46 and a 200 day moving average price of $3.31. The company has a market cap of $349.93 million, a PE ratio of 12.21, a price-to-earnings-growth ratio of 2.91 and a beta of 0.91.
DocGo (NASDAQ:DCGO – Get Free Report) last released its quarterly earnings results on Wednesday, August 7th. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.07 by ($0.01). DocGo had a return on equity of 8.90% and a net margin of 3.97%. The company had revenue of $164.95 million for the quarter, compared to analyst estimates of $166.61 million. As a group, sell-side analysts expect that DocGo Inc. will post 0.23 earnings per share for the current year.
DocGo Company Profile
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Further Reading
- Five stocks we like better than DocGo
- Consumer Discretionary Stocks Explained
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- 3 Healthcare Dividend Stocks to Buy
- MarketBeat Week in Review – 10/21- 10/25
Want to see what other hedge funds are holding DCGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocGo Inc. (NASDAQ:DCGO – Free Report).
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.